LEADER 01220nam0 2200313 450 001 000020137 005 20070709111350.0 010 $a0-691-09493-4 100 $a20070613d2000----km-y0itaa50------ba 101 0 $aeng 102 $aUS 200 1 $aHadrian and the cities of the Roman empire$fMary T. Boatwright 210 $aPrinceton$cPrinceton University Press$dc2000 215 $aXVIII, 243 p.$cill.$d24 cm. 600 0$aAdriano$c 606 $aRoma 676 $a937.07$v(21. ed.)$9Storia dell'antica penisola italica e territori adiacenti. Primo periodo e periodo intermedio, 31 a.C.-284 700 1$aBoatwright,$bMary Taliaferro$0259774 801 0$aIT$bUniversità della Basilicata - B.I.A.$gRICA$2unimarc 912 $a000020137 996 $aHadrian and the cities of the Roman empire$986145 997 $aUNIBAS BAS $aLETTERE CAT $aSTD052$b01$c20070613$lBAS01$h1157 CAT $aSTD053$b01$c20070613$lBAS01$h1443 CAT $aSTD053$b01$c20070613$lBAS01$h1608 CAT $aATR$b30$c20070709$lBAS01$h1113 FMT Z30 -1$lBAS01$LBAS01$mBOOK$1BASA4$APolo di Matera$2GEN$BCollezione generale$3MSR-L III-132$6105828$5L105828$820070613$f02$FPrestabile Generale LEADER 01977oam 2200457Ia 450 001 9910698954603321 005 20090820090806.0 035 $a(CKB)5470000002398329 035 $a(OCoLC)421097512 035 $a(EXLCZ)995470000002398329 100 $a20090702d2008 ua 0 101 0 $aeng 135 $auran||||||||| 181 $ctxt$2rdacontent 182 $cc$2rdamedia 183 $acr$2rdacarrier 200 00$aGuidance for industry$b[electronic resource] $epostmarketing adverse event reporting for medical products and dietary supplements during an influenza pandemic 210 1$aRockville, MD :$cU.S. Dept. of Health and Human Services, Food and Drug Administration, Office of Counterterrorism and Emerging Threats :$cCenter for Drug Evaluation and Research :$cCenter for Biologics Evaluation and Research :$cCenter for Devices and Radiological Health :$cCenter for Food Safety and Applied Nutrition,$d[2008] 215 $a1 online resource (12 pages) 300 $a"Draft guidance". 300 $a"Procedural". 300 $a"December 2008". 517 $aGuidance for industry 606 $aDrugs$xSide effects$xReporting$xGovernment policy$zUnited States 606 $aDietary supplements$xGovernment policy$zUnited States 606 $aInfluenza 615 0$aDrugs$xSide effects$xReporting$xGovernment policy 615 0$aDietary supplements$xGovernment policy 615 0$aInfluenza. 712 02$aUnited States.$bFood and Drug Administration.$bOffice of Counterterrorism and Emerging Threats. 712 02$aCenter for Drug Evaluation and Research (U.S.) 712 02$aCenter for Biologics Evaluation and Research (U.S.) 712 02$aCenter for Devices and Radiological Health (U.S.) 712 02$aCenter for Food Safety and Applied Nutrition (U.S.) 801 0$bGPO 801 1$bGPO 801 2$bGPO 906 $aBOOK 912 $a9910698954603321 996 $aGuidance for industry$93434577 997 $aUNINA